January 31, 2018 / 12:43 PM / 3 months ago

BRIEF-Protalix Biotherapeutics' Pegunigalsidase Alfa Receives Fast Track Designation From FDA

1 分钟阅读

Jan 31 (Reuters) - Protalix Biotherapeutics Inc:

* PROTALIX BIOTHERAPEUTICS’ PEGUNIGALSIDASE ALFA RECEIVES FAST TRACK DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below